SARS-CoV-2 Modelo de Inoculación en la Cavidad Oral. Revisión de la Literatura

Villanueva-Sánchez, Francisco Germán; Escalante-Macías, Lilia Haidé.
Int. j. odontostomatol. (Print) ; 14(4): 495-500, dic. 2020. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1134526

Documentos relacionados

  1. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
  2. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
  3. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
  4. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
  5. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
  6. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
  7. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.
  8. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
  9. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
  10. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.